Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	33.18	66.89	130.1	122.16	43.78	6.55
Short-Term Investments	167.16	176.64	47.5	72.08	-	-
Cash & Short-Term Investments	200.34	243.52	177.61	194.24	43.78	6.55
Cash Growth	-7.00%	37.11%	-8.56%	343.70%	568.15%	-
Accounts Receivable	-	-	-	-	0.11	0.03
Other Receivables	0.32	0.4	0.11	0.1	-	-
Receivables	0.32	0.4	0.11	0.1	0.11	0.03
Inventory	0.14	0.1	0.2	0.08	0.09	0.05
Prepaid Expenses	1.01	0.81	1.11	1.51	0.01	-
Other Current Assets	5.82	1.79	1.31	2.73	0.45	0.55
Total Current Assets	207.63	246.62	180.33	198.66	44.43	7.18
Property, Plant & Equipment	0.39	0.5	0.27	0.04	-	-
Long-Term Investments	58.55	62.55	15.84	31.62	-	-
Other Long-Term Assets	0.28	0.45	0.15	0.01	-	0.14
Total Assets	266.98	310.13	196.59	230.33	44.43	7.32
Accounts Payable	2.34	1.38	1.64	1.09	0.53	0.22
Accrued Expenses	17.24	10.51	5.94	3.86	0.33	0.51
Current Portion of Leases	0.13	0.87	0.11	-	-	-
Other Current Liabilities	0.2	0.21	0.13	0.2	5.5	0.61
Total Current Liabilities	19.91	12.97	7.81	5.15	6.37	1.34
Long-Term Debt	29.67	29.9	-	-	-	-
Long-Term Leases	0.19	0.28	-	-	-	-
Total Liabilities	49.77	43.15	7.81	5.15	6.37	1.34
Common Stock	0.01	0.01	0	0	-	-
Additional Paid-In Capital	504.65	489.45	359.95	352.98	8.37	8.22
Retained Earnings	-287.97	-222.8	-170.43	-127.57	-26.97	-19.64
Comprehensive Income & Other	0.52	0.31	-0.75	-0.23	-	-
Total Common Equity	217.2	266.97	188.78	225.18	-18.59	-11.42
Shareholders' Equity	217.2	266.97	188.78	225.18	38.06	5.98
Total Liabilities & Equity	266.98	310.13	196.59	230.33	44.43	7.32
Total Debt	29.99	31.05	0.11	-	-	-
Net Cash (Debt)	228.91	275.03	193.34	225.86	43.78	6.55
Net Cash Growth	-19.03%	42.25%	-14.40%	415.92%	568.15%	-
Net Cash Per Share	3.85	5.66	4.76	11.26	104.45	15.21
Filing Date Shares Outstanding	60.08	60.08	41.03	40.47	0.42	0.43
Total Common Shares Outstanding	60.08	57.91	41.03	40.47	0.42	0.43
Working Capital	187.72	233.64	172.52	193.51	38.06	5.84
Book Value Per Share	3.62	4.61	4.60	5.56	-44.35	-26.50
Tangible Book Value	217.2	266.97	188.78	225.18	-18.59	-11.42
Tangible Book Value Per Share	3.62	4.61	4.60	5.56	-44.35	-26.50

Source: S&P Capital IQ. Standard template. Financial Sources.